PAM
IHE icon

PVG Asset Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

PVG Asset Management’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-16,155
Closed -$842K – 89
2017
Q3 		$842K Buy
+16,155
New +$829K 0.37% 59

Other funds holding IHE

CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AWA
ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PVG Asset Management's IHE Position: Q4 2017 in Review

PVG Asset Management sold out of iShares US Pharmaceuticals ETF (IHE) in Q4 2017, closing a stake of 16,155 shares — an estimated $842K sold.

PVG Asset Management first reported a position in IHE in Q3 2017 and held it in 1 quarter. The position peaked at $842K in Q3 2017. 108 funds tracked by Wall St. Rank hold IHE as of Q4 2017.

  • PVG Asset Management reported no remaining iShares US Pharmaceuticals ETF position as of Q4 2017 after selling out during the quarter.
  • PVG Asset Management sold 16,155 iShares US Pharmaceuticals ETF shares in Q4 2017, an estimated $842K.
  • PVG Asset Management first reported a position in iShares US Pharmaceuticals ETF in Q3 2017 and held it in 1 quarter.
  • PVG Asset Management's iShares US Pharmaceuticals ETF position peaked at $842K in Q3 2017.
  • 108 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2017.

Based on PVG Asset Management's 13F filing for Q4 2017, filed 15 Feb 2018.